LIFECORE BIOMEDICAL, INC. Public Float
LIFECORE BIOMEDICAL, INC. (LFCR) had Public Float of $222.97 million as of 2025-06-30, per its 10-KT filed 2026-03-16.
Financial Statements › Notes › Cover Page
dei:EntityPublicFloat · last filed 2026-03-16
- 2025-06-30: Entity Public Float $222.97M.
- 2024-11-22: Entity Public Float $201.59M.
- 2023-11-26: Entity Public Float $153.87M.
- 2022-11-27: Entity Public Float $180.94M.
| Period end | Entity Public Float | Entity Public Float as first filed |
|---|---|---|
| 2025-06-30 | $222.97M 10-KT · filed 2026-03-16 | |
| 2024-11-22 | $201.59M 10-K · filed 2025-08-07 | |
| 2023-11-26 | $153.87M 10-K · filed 2024-08-26 | |
| 2022-11-27 | $180.94M 10-K · filed 2024-03-20 | |
| 2020-11-29 | $225.36M 10-K/A · filed 2023-03-16 | $210.11M 10-K · filed 2021-07-29 |
| 2019-11-24 | $295.75M 10-K · filed 2020-08-14 | |
| 2018-11-23 | $351.94M 10-K · filed 2019-08-01 | |
| 2017-11-26 | $294.83M 10-K · filed 2018-08-09 | |
| 2016-11-25 | $297.20M 10-K/A · filed 2018-03-15 | |
| 2015-11-29 | $332.04M 10-K · filed 2016-08-01 | |
| 2014-11-30 | $344.75M 10-K · filed 2015-07-31 | |
| 2013-11-24 | $294.14M 10-K · filed 2014-08-01 | |
| 2012-11-25 | $233.85M 10-K · filed 2013-08-07 | |
| 2011-11-27 | $126.20M 10-K · filed 2012-08-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ADC Therapeutics SA (ADCT) | $0.163B | -1.39 | |
| Minerva Neurosciences, Inc. (NERV) | United States | $0.165B | -0.66 |
| Tonix Pharmaceuticals Holding Corp. (TNXP) | United States | $0.166B | -1.34 |
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |
| Organogenesis Holdings Inc. (ORGO) | United States | $0.182B | -3.70 |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B |